The Lenire® tinnitus treatment device is now available in Canada through 21 clinics across Alberta, British Colombia, Manitoba, Ontarioand Québec.
Forty-three percent of Canadians (11.2 million) report experiencing tinnitus in their lifetime, with 37% (9.2 million) experiencing tinnitus in the past year, according to data from a Canadian Health Measures Survey (CHMS).
Lenire is the first bimodal neuromodulation device that has been proven to provide long-term relief from tinnitus across multiple clinical trials. Lenire combines mild pulses to the tongue via a ‘Tonguetip®’, with auditory stimulation to drive changes to the brain and deliver longterm relief from tinnitus.
“Lenire has been a miracle that has changed my life,” said Toronto-based tinnitus patient, Jim Gray.
Lenire’s Canada availability follows a comprehensive audit that verified Neuromod’s compliance with the international standard ISO13485 and regulatory requirements in multiple regulatory jurisdictions including Canada (Health Canada).
FURTHER INFORMATION:
Lenire
info@lenire.com
www.lenire.com
www.lenire.com/find-a-clinic
